CD8A and neoplasm: Weisshaar et al. [79] demonstrated that RGS16 promotes anti-tumor CD8+ T lymphocyte exhaustion and limits their survival by interaction with scaffold protein IQ motif–containing GTPase-activating protein 1 (IQGAP1).